1. Home
  2. RVNC vs WEYS Comparison

RVNC vs WEYS Comparison

Compare RVNC & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • WEYS
  • Stock Information
  • Founded
  • RVNC 1999
  • WEYS N/A
  • Country
  • RVNC United States
  • WEYS United States
  • Employees
  • RVNC N/A
  • WEYS N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • RVNC Health Care
  • WEYS Consumer Staples
  • Exchange
  • RVNC Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • RVNC 292.5M
  • WEYS 285.4M
  • IPO Year
  • RVNC 2014
  • WEYS N/A
  • Fundamental
  • Price
  • RVNC $3.98
  • WEYS $33.19
  • Analyst Decision
  • RVNC Buy
  • WEYS
  • Analyst Count
  • RVNC 9
  • WEYS 0
  • Target Price
  • RVNC $12.00
  • WEYS N/A
  • AVG Volume (30 Days)
  • RVNC 1.9M
  • WEYS 14.3K
  • Earning Date
  • RVNC 08-06-2024
  • WEYS 08-06-2024
  • Dividend Yield
  • RVNC N/A
  • WEYS 3.13%
  • EPS Growth
  • RVNC N/A
  • WEYS N/A
  • EPS
  • RVNC N/A
  • WEYS 3.07
  • Revenue
  • RVNC $236,645,000.00
  • WEYS $303,312,000.00
  • Revenue This Year
  • RVNC $20.63
  • WEYS N/A
  • Revenue Next Year
  • RVNC $34.80
  • WEYS N/A
  • P/E Ratio
  • RVNC N/A
  • WEYS $10.84
  • Revenue Growth
  • RVNC 54.59
  • WEYS N/A
  • 52 Week Low
  • RVNC $2.30
  • WEYS $24.47
  • 52 Week High
  • RVNC $24.87
  • WEYS $33.70
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 75.07
  • WEYS 72.56
  • Support Level
  • RVNC $2.40
  • WEYS $28.13
  • Resistance Level
  • RVNC $4.31
  • WEYS $33.67
  • Average True Range (ATR)
  • RVNC 0.27
  • WEYS 0.84
  • MACD
  • RVNC 0.20
  • WEYS 0.48
  • Stochastic Oscillator
  • RVNC 93.00
  • WEYS 98.38

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: